Certara Customers Received 90 Percent of US FDA Novel Drug Approvals for 8th Consecutive Year
15 févr. 2022 16h30 HE
|
Certara
PRINCETON, N.J., Feb. 15, 2022 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that 90 percent of new drug approvals by the U.S. Food and Drug...
Certara to Report Fourth Quarter and Full Year 2021 Financial Results on March 1st, 2022
08 févr. 2022 16h30 HE
|
Certara
PRINCETON, N.J., Feb. 08, 2022 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release financial results for the fourth quarter and...
Certara Announces FDA Renewal and Expansion of Certara’s Biosimulation Software for Reviewing Regulatory Submissions
21 déc. 2021 08h00 HE
|
Certara
PRINCETON, N.J., Dec. 21, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that the U.S. Food and Drug Administration (FDA) has renewed and...
Certara Announces Release of Pinnacle 21 Enterprise Software
13 déc. 2021 08h00 HE
|
Certara
PRINCETON, N.J., Dec. 13, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the feature release of Pinnacle 21 Enterprise 5.1.0, which updates...
Certara to Host Investor Day on December 15, 2021
08 déc. 2021 17h00 HE
|
Certara
PRINCETON, N.J., Dec. 08, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, will host an Investor Day on Wednesday, December 15, 2021 from 3:00 PM to 6:00 PM...
Certara 宣布两项重要人事任命，中国团队发展壮大
03 déc. 2021 06h42 HE
|
Certara USA, Inc.
新泽西州普林斯顿, Dec. 03, 2021 (GLOBE NEWSWIRE) -- 日快讯。全球生物模拟科技行业巨头 Certara, Inc.（纳斯达克股票代码：CERT）今日宣布任命李改玲博士为高级副总裁兼中国区首席科学官，并任命张静为监管科学业务发展部总监。Certara 上海办事处的这两项人事任命旨在为中国生物制药公司提供更多本地支持，将进一步推动公司在全球不断向前发展。 ...
Certara Announces Release of Simcyp™ Simulator Version 21, Expanding Capabilities to Align with Recent Regulatory Guidances
02 déc. 2021 08h00 HE
|
Certara
PRINCETON, N.J., Dec. 02, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the release of Simcyp Simulator Version 21, which updates the...
Certara Announces Update of D360™ Scientific Informatics Software
29 nov. 2021 16h30 HE
|
Certara
PRINCETON, N.J., Nov. 29, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the release of D360 version 21.5, an industry-leading scientific...
Certara Announces Closing of Public Offering of Common Stock
22 nov. 2021 17h45 HE
|
Certara
PRINCETON, N.J., Nov. 22, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the closing of its underwritten public offering of 10,000,000...
Certara Announces Pricing of Public Offering of Common Stock
17 nov. 2021 23h27 HE
|
Certara
PRINCETON, N.J., Nov. 17, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the pricing of its underwritten public offering of 10 million...